Portuguese Oncology Institute, Coimbra Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2015
NCT02357303
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Gastroenterology Department, Portuguese Oncology Institute - Coimbra | Portuguese Oncology Institute, Coimbra

Active Ingredients

Drugs in Phase 4 Trials (2)

acetylcysteine (mucomyst) (1 trial)

simethicone (IMODIUM) (2 trials)

Drugs in Other Trials (1)

polyethylene glycol (1 trial)

Indications

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3